ORGANISMOS CON RESISTENCIA A MÚLTIPLES DROGAS Y MECANISMOS DE REVERSIÓN

Edson Daniel Hernández Velázquez, Cesar Rogelio Solorio-Alvarado

Resumen


En este escrito se hace realiza una exposición de diferentes tipos de organismos con la capacidad de presentar resistencia a medicamentos. Estos son acompañados por los mecanismos encargados de lograr dicha resistencia, los peligros que implican y las perspectivas que dicha problemática genera en la comunidad científica, especialmente en el área de síntesis orgánica y farmacia. Se listan los mecanismos de reversión de dicha resistencia y sus posibles dianas biológicas que serán de utilidad al lector, como apoyo en la investigación y desarrollo de nuevos prospectos de medicamento, capaces de revertir tal inminente amenaza.

Texto completo:

PDF

Referencias


Anderson N.M., Simon M.C., (2020). The tumor microenvironment. Current Biology, 30 (16), R905–R931. https://doi.org/10.1016/j.cub.2020.06.081 Boger D.L, Soenen D.R., Boyce C.W., Hedrick M.P., Jin Q. (2000). Total Synthesis of Ningalin B Utilizing a Heterocyclic Azadiene Diels−Alder Reaction and Discovery of a New Class of Potent Multidrug Resistant (MDR) Reversal Agents. Journal of Organic Chemistry, 65, 2479-2483.

Borges-Walmsley, M., McKeegan, K.S., (2003). Structure and function of efflux pumps that confer resistance to drugs. Biochemical Journal, 376, 313-338. https://doi.org/10.1042/bj20020957

Cano J.R.G, Nahide P.D., Ramadoss V., Satkar Y., Ortiz-Alvarado R., Alba-Betancourt C., Mendoza-Macías C.L., Solorio-Alvarado C.R., (2017). Synthesis and Biological Evaluation of New 3,4-diarylmaleimides as Enhancers (modulators) of Doxorubicin Cytotoxic Activity on Cultured Tumor Cells from a Real Case of Breast Cancer. Journal of the Mexican Chemistry Society, 61, 41-49.

Cano J.R.G, Nahide P.D., Ramadoss V., Satkar Y., Ortiz-Alvarado R., Alba-Betancourt C., Mendoza-Macías C.L., Solorio-Alvarado C.R., (2017). Synthesis and Biological Evaluation of New 3,4-diarylmaleimides as Enhancers (modulators) of Doxorubicin Cytotoxic Activity on Cultured Tumor Cells from a Real Case of Breast Cancer. Journal of the Mexican Chemistry Society, 61, 41-49.

Davies J., Davies D. (2010). Origins and evolution of antibiotic resistance. Microbiology And Molecular Biology Reviews, 74(3), 417-433. https://doi.org/10.1128/mmbr.00016-10

Desai P.V., Raub, T.J., Blanco M.J. (2012). How hydrogen bonds impact P-glycoprotein transport and permeability. Bioorganic and Medical Chemistry Letters, 22(21), 6540-6548. https://doi.org/10.1016/j.bmcl.2012.08.059

Ecker A., Lehane A.M., Clain J., Fidock D.A. (2012). PfCRT and its role in antimalarial drug resistance. Trends in Parasitology, 28(11), 504-514. https://doi.org/10.1016/j.pt.2012.08.002

Emran, T.B, Shahriar, A., Mahmud A.R., Rahman, T., Abir, M.H., Siddiquee, M.F.R, Ahmed, H., Rahman, N., Nainu, F., Wahyudin, E., Mitra, S., Dhama, K., Habiballah, M.M., Haque, S., Islam, A., Hassan, M.M. (2022). Multidrug Resistance in Cancer: Understanding Molecular Mechanisms, Immunoprevention and Therapeutic Approaches. Frontiers in Oncology, 12, 891652. https://doi.org/10.3389/fonc.2022.891652

Farrell, M.L., Chueiri, A., O’Connor, L., Duane, S. Maguire, M., Miliotis, G., Cormican, M., Hooban, B., Leonard, A., Gaze, W.H., Devane, G., Tuohy, A., Burke, L.P., Morris, D. (2023). Assessing the impact of recreational water use on carriage of antimicrobial resistant organisms.Science of the Total Environment, 888, 164201. https://doi.org/10.1016/j.scitotenv.2023.164201

Fernández-Villa D., Aguilar M.R., Rojo L. (2019). Folic Acid Antagonists: Antimicrobial and Immunomodulating Mechanisms and Applications. International Journal of Molecular Sciences, 20(20), 4996. https://doi.org/10.3390/ijms20204996

Ganapathi R., Grabowski D., Turinic R., Valenzuela R. (1984). Correlation between potency of calmodulin inhibitors and effects on cellular levels and cytotoxic activity of doxorubicin (adriamycin) in resistant P388 mouse leukemia cells. European Journal of Cancer Clinical Oncology, 20(6), 799-806. https://doi.org/10.1016/0277-5379(84)90219-0

Gulshan K., Moye-Rowley W.S. (2007). Multidrug Resistance in Fungi. Eukaryotic Cell, 6(11), 1933-1942. https://doi.org/10.1128/EC.00254-07

Hardwick M.J., Soane L. (2013). Multiple functions of BCL-2 family proteins. Cold Spring Harbor Perspect Biology, 5(2), a008722. https://doi.org/10.1101/cshperspect.a008722

Hinds M., Deisseroth K., Mayes J., Altschuler E., Jansen R., Ledley F.D., Zwelling L.A. (1991). Novel actions of inhibitors of DNA topoisomerase II in drug-resistant tumor cells. Cancer Chemotherapy and Pharmacology, 34, S14-S18. https://doi.org/10.1007/bf00684858

Hipfner D.R., Deeley R.G., Cole S.P. (1999). Structural, mechanistic and clinical aspects of MRP1. Biochemistry and Biophysiology Acta, 1461(2), 359-376. https://doi.org/10.1016/s0005-2736(99)00168-6

Huang D., Duan H., Huang H., Tong X., Han Y., Ru G. (2016). Cisplatin resistance in gastric cancer cells is associated with HER2 upregulation-induced epithelial-mesenchymal transition. Scientific Reports, 6, 20502. https://doi.org/10.1038/srep20502

Hyde J.E. (2022). Mechanisms of resistance of Plasmodium falciparum to antimalarial drugs. Microbes and Infection, 4(2), 165-174. https://doi.org/10.1016/s1286-4579(01)01524-6

Koning H.P., Anderson L.F., Stewart M., Burchmore R.J.S., Wallace L.J.M., Barrett M.P. (2004). The Trypanocide Diminazene Aceturate Is Accumulated Predominantly through the TbAT1 Purine Transporter: Additional Insights on Diamidine Resistance in African Trypanosomes. Antimicrobial Agents Chemotherapy. 48(5), 1515-1519. https://doi.org/10.1128/AAC.48.5.1515-1519.2004

Koning H.P. (2017). Drug resistance in protozoan parasites. Emerging Topics in Life Sciences, 1(6), 627-632. https://doi.org/10.1042/ETLS20170113

Kowalskia C.H., Morellia K.A., Schultza D., Nadellb C.D., Cramer R.A. (2020). Fungal biofilm architecture produces hypoxic microenvironments that drive antifungal resistance. Proc Natl AcadS, 117, 22473-22483. https://doi.org/10.1073/pnas.2003700117

Krishna R., Mayer L.D. (2000). Multidrug resistance (MDR) in cancer. Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs. European Journal of Pharmaceutical Sciences, 11, 265-283. https://doi.org/10.1016/s0928-0987(00)00114-7

Kukl J.S., Sikic B.I., Blume K.G., Chao N.J. (1992). Use of etoposide in combination with cyclosporine for purging multidrug resistant leukemic cells from bone marrow in a mouse model. Experimental Hematology, 20, 1048-1054.

Kurrey N.K., Jalgaonkar S.P., Joglekar A.V., Ghanate A.D., Chaskar P.D. (2009). Snail and slug mediate radioresistance and chemoresistance by antagonizing p53-mediated apoptosis and acquiring a stem-like phenotype in ovarian cancer cells. Stem Cells, 27, 2059-2068. https://doi.org/10.1002/stem.154

Lee H.J., Zhuang G., Cao Y., Du P., Kim H.J., Settleman J. (2014). Drug resistance via feedback activation of Stat3 in oncogene-addicted cancer cells. Cancer Cell, 26, 207-221. https://doi.org/10.1016/j.ccr.2014.05.019

Li Z.W., Dalton W.S. (2006). Tumor microenvironment and drug resistance in hematologic malignancies. Blood Reviews, 20, 333-342. https://doi.org/10.1016/j.blre.2005.08.003

Li J., Jaimes K.F., Aller S.G. (2014). Refined structures of mouse P-glycoprotein. Protein Science, 23, 34-46. https://doi.org/10.1002/pro.2387

Li-Blatter X., Seelig A. (2010). Exploring the P-Glycoprotein Binding Cavity with Polyoxyethylene Alkyl Ethers. Biophysical Journal, 99, 3589-3598. https://doi.org/10.1016/j.bpj.2010.10.033

Mansoori, B., Mohammadi, A., Davudian, S., Shirjang, S., Baradaran, B. (2017). The Different Mechanisms of Cancer Drug Resistance: A Brief Review. Advanced Pharmaceutical Bulletin, 7(3), 339-348. https://doi.org/10.15171/apb.2017.041

Mao Q., Unadkat J.D. (2015). Role of the Breast Cancer Resistance Protein (BCRP/ABCG2) in Drug Transport—an Update. The AAPS Journal, 17, 65-182. https://doi.org/10.1208/s12248-014-9668-6

Mercier C., Masseguin C., Roux F. (2004). Expression of P-glycoprotein (ABCB1) and Mrp1 (ABCC1) in adult rat brain: focus on astrocytes. Brain Research, 1021, 32–40.

Mo W., Zhang J.T. (2012). Human ABCG2: structure, function, and its role in multidrug resistance. International Journal of Biochemistry and Molecular Biology, 3, 1-27.

Pagter M.S., Kloosterman W.P. (2015). The Diverse Effects of Complex Chromosome Rearrangements and Chromothripsis in Cancer Development. Chromosomal Instability in Cancer Cells, 200, 165-193. https://doi.org/10.1007/978-3-319-20291-4_8

Pfaller M.A., Diekema D.J., Jones R.N., Sader H.S., Fluit A.C., Hollis R.J., Messer S.A. (2001). International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surveillance program. Journal of Clinical Microbiology, 39, 3254-3259. https://doi.org/10.1128/jcm.39.9.3254-3259.2001

Pirker R., Keilhauer G., Raschack M., Lechner C., Ludwig H. (1990). Re versal of multi-drug resistance in human KB cell lines by structural analogs of verapamil. International Journal of Cancer, 45, 916-919. https://doi.org/10.1002/ijc.2910450523

Preissler S., Rato C., Yan Y., Perera L.A., Czako A., Ron D. (2020). Calcium depletion challenges endoplasmic reticulum proteostasis by destabilising BiP-substrate complexes. eLife. 9, e62601.

Rank G.H., Robertson A.J., Phillips K.L. (1975). Modification and inheritance of pleiotropic cross resistance and collateral sensitivity in Saccharomyces cerevisiae. Genetics, 80, 783-793.

Reyn A., Korner B., Bentzon M.W. (1958). Effects of penicillin, streptomycin, and tetracycline on N. gonorrhoeae isolated in 1944 and in 1957. British Journal of Venereal Diseases, 34, 227-239. https://doi.org/10.1136/sti.34.4.227

Ren Y., Wang C., Chen Z., Allan E., van der Mei H.C., Busscher H.J. (2018). Emergent heterogeneous microenvironments in biofilms. FEMS Microbiology Reviews, 42, 259-272. https://doi.org/10.1093/femsre/fuy001

Saha M., Sarkar S.J. (2021), Review on Multiple Facets of Drug Resistance: A Rising Challenge in the 21st Century. Xenobiot, 11, 197-214. https://doi.org/10.3390/jox11040013

Sampath D., Cortes J., Estrov Z., Du M., Shi Z., Andreeff M. (2006). Pharmacodynamics of cytarabine alone and in combination with 7-hydroxystaurosporine (UCN-01) in AML blasts in vitro and during a clinical trial. Blood, 107, 2517-2524. https://doi.org/10.1182/blood-2005-08-3351

Sarkadi B., Homolya L., Heged T. (2020). The ABCG2/BCRP transporter and its variants – from structure to pathology. FEBS Letters, 594, 4012-4034. https://doi.org/10.1002/1873-3468.13947

Seelig A. (2020). P-Glycoprotein: One Mechanism, Many Tasks and the Consequences for Pharmacotherapy of Cancers. Frontiers in Oncology, 10, 576559. https://doi.org/10.3389/fonc.2020.576559

Sigismund S., Avanzato D., Lanzetti L. (2018). Emerging functions of the EGFR in cancer. Cancer Molecular Oncology, 12, 3-20. https://doi.org/10.1002/1878-0261.12155

Solary E., Velay I., Chauffert B., Caillot D., Bidan M.J., Dumas M., Cassanovas O., Guy H. (1990). Sufficient levels of quinine in serum circumvent the multidrug resistance of leukemic cell line K562/ADM. Cancer, 32, 361.

Tsuruo T., Lida H., Tsukagoshi S., Sakurai Y. (1981). Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil. Cancer Research, 41, 1967-1972.

Tulsyan S., Mittal R.D., Mittal B. (2016). The effect of ABCB1 polymorphisms on the outcome of breast cancer treatment. Pharmacogenomics Personalized Medicine, 9, 47.58. https://doi.org/10.2147/pgpm.s86672

Unemo M., Shafer W.M. (2014). Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and future. Clinical Microbiology Reviews, 27, 587-613. https://doi.org/10.1128/cmr.00010-14

Vasiliou V., Vasiliou K., Nebert D.W. (2009). Human ATP-binding cassette (ABC) transporter family. Human Genomics, 3, 281–290.

Wallace, K., Asemota, H., Gray, W. (2021). Acetone Extract of Dioscorea alata Inhibits Cell Proliferation in Cancer Cells. American Journal of Plant Sciencies, 12(3), 300-314. https://doi.org/10.4236/ajps.2021.123019

Wang J., Seebacher N., Shi H., Kan H.Q., Duan Z. (2017). Novel strategies to prevent the development of multidrug resistance (MDR) in cancer. Oncotarget, 8(48), 84559-84571. https://doi.org/10.18632/oncotarget.19187

Watanabe T., Naito M., Oh-hara T., Itoh Y., Cohen D., Tsuruo T. (1996). Modulation of Multidrug Resistance by SDZ PSC 833 in Leukemic and Solid‐tumor‐bearing Mouse Models. Jpn. Journal of Cancer Research, 87(2), 184-193. https://doi.org/10.1111/j.1349-7006.1996.tb03157.x

Wojtuszkiewicz A., Peters G.J., Van Woerden V.L., Dubbelman B., Escherich G., Schmiegelow K., Sonneveld E., Pieters R., Van de Ven P.M., Jansen G., Assaraf G.Y., Kaspers G.J.L., Cloos J. (2015). Methotrexate resistance in relation to treatment outcome in childhood acute lymphoblastic leukemia. Journal of Hematology & Oncology, 8, 61. https://doi.org/10.1186/s13045-015-0158-9

Yin J.Y., Huang Q., Yang Y. (2009). Multidrug resistance-associated protein 1 (MRP1/ABCC1) polymorphism: from discovery to clinical application. Pharmacogenet Genomics, 36(10), 927-938. https://doi.org/10.3969/j.issn.1672-7347.2011.10.002

Zhang, Y., Cao, Y., Zhang, L., Feng, C., Zhou, G., Wen, G. (2018). Apigenin inhibits C5a-induced proliferation of human nasopharyngeal carcinoma cells through down-regulation of C5aR. Bioscience Reports, 38, BSR20180456. https://doi.org/10.1042/bsr20180456


Enlaces refback

  • No hay ningún enlace refback.


Naturaleza y Tecnología, revista electrónica de la División de Ciencias Naturales y Exactas del campus Guanajuato, Universidad de Guanajuato. En ella se reciben para su revisión y arbitraje, artículos originales de investigación, artículos de revisión sobre temas actuales de investigación, así como ensayos sobre diversas temáticas del mundo científico y académico en las áreas de la química, matemáticas, ingeniería, astronomía, biología y farmacia, dentro del ámbito que comprenden las ciencias naturales y exactas, siendo requerido que no hayan sido publicadas o en proceso de publicación en otras revistas. Cuenta también con un Facebook de notas científicas de actualidad como apoyo a la actividad académica de la comunidad universitaria y para conocimiento del público en general como parte de un programa de divulgación científica y tecnológica.

.